Imagine knowing the future health

of every clinical trial participant

at the beginning of your study

Imagine knowing the future health

of every clinical trial participant

at the beginning of your study

Every clinical outcome at every future time point.

Predicted with unparalleled precision.

Every clinical outcome at every future time point.

Predicted with unparalleled precision.

We create digital twins of your patients.

Delivered through a
state-of-the-artplatform

We've made simple to use that puts the power ofAI in your hands.

Solutions

What can the Unlearn Platform do for you?

Discover how the Unlearn Platform can enhance your trial’s efficiency, insights, and impact, tailored to your needs. Explore a few of our solutions below and book a demo to learn how we can support your trial goals.

Solutions

What can the Unlearn Platform do for you?

Discover how the Unlearn Platform can enhance your trial’s efficiency, insights, and impact, tailored to your needs. Explore a few of our solutions below and book a demo to learn how we can support your trial goals.

01.

Accelerate Trial Timelines with Smaller, More Efficient Studies

Design and run smaller clinical trials that maintain power or more powerful studies without requiring additional participants. This approach is qualified by the EMA and aligns with current FDA guidance.

02.

Enhance Decision-making with Digital Twins

See predicted outcomes for any subgroup of participants for all measured clinical variables at any point in time. Gain real-time insights and make more informed, data-driven decision-making throughout the trial.

03.

Identify Sensitive Clinical Outcomes

Generate participants’ digital twins resembling your study’s target patient population during trial planning to optimize study endpoints and composite scores, enhancing sensitivity at both the population and subpopulation levels.

The Unlearn Platform

Control Arm Size Reduction*
33
%
Estimated Cost Savings*
$
50
M
*Approximate values

Accelerating Clinical Development in Alzheimer’s Disease

We work in neuroscience, immunology, metabolic disease, and more.

View Case Study